151 related articles for article (PubMed ID: 9736005)
1. Brain dopamine transporter messenger RNA and binding sites in cocaine users: a postmortem study.
Little KY; McLaughlin DP; Zhang L; McFinton PR; Dalack GW; Cook EH; Cassin BJ; Watson SJ
Arch Gen Psychiatry; 1998 Sep; 55(9):793-9. PubMed ID: 9736005
[TBL] [Abstract][Full Text] [Related]
2. Striatal dopaminergic abnormalities in human cocaine users.
Little KY; Zhang L; Desmond T; Frey KA; Dalack GW; Cassin BJ
Am J Psychiatry; 1999 Feb; 156(2):238-45. PubMed ID: 9989560
[TBL] [Abstract][Full Text] [Related]
3. Progression of changes in dopamine transporter binding site density as a result of cocaine self-administration in rhesus monkeys.
Letchworth SR; Nader MA; Smith HR; Friedman DP; Porrino LJ
J Neurosci; 2001 Apr; 21(8):2799-807. PubMed ID: 11306632
[TBL] [Abstract][Full Text] [Related]
4. Regulation of rat dopamine transporter mRNA and protein by chronic cocaine administration.
Letchworth SR; Sexton T; Childers SR; Vrana KE; Vaughan RA; Davies HM; Porrino LJ
J Neurochem; 1999 Nov; 73(5):1982-9. PubMed ID: 10537056
[TBL] [Abstract][Full Text] [Related]
5. Dopamine transport function is elevated in cocaine users.
Mash DC; Pablo J; Ouyang Q; Hearn WL; Izenwasser S
J Neurochem; 2002 Apr; 81(2):292-300. PubMed ID: 12064476
[TBL] [Abstract][Full Text] [Related]
6. Cocaine use increases [3H]WIN 35428 binding sites in human striatum.
Little KY; Kirkman JA; Carroll FI; Clark TB; Duncan GE
Brain Res; 1993 Nov; 628(1-2):17-25. PubMed ID: 8313144
[TBL] [Abstract][Full Text] [Related]
7. Cocaine induction of dopamine transporter trafficking to the plasma membrane.
Little KY; Elmer LW; Zhong H; Scheys JO; Zhang L
Mol Pharmacol; 2002 Feb; 61(2):436-45. PubMed ID: 11809869
[TBL] [Abstract][Full Text] [Related]
8. Effects of chronic cocaine administration on dopamine transporter mRNA and protein in the rat.
Letchworth SR; Daunais JB; Hedgecock AA; Porrino LJ
Brain Res; 1997 Mar; 750(1-2):214-22. PubMed ID: 9098547
[TBL] [Abstract][Full Text] [Related]
9. Cocaine, ethanol, and genotype effects on human midbrain serotonin transporter binding sites and mRNA levels.
Little KY; McLaughlin DP; Zhang L; Livermore CS; Dalack GW; McFinton PR; DelProposto ZS; Hill E; Cassin BJ; Watson SJ; Cook EH
Am J Psychiatry; 1998 Feb; 155(2):207-13. PubMed ID: 9464199
[TBL] [Abstract][Full Text] [Related]
10. Lack of dopamine receptor agonists effect on striatal dopamine transporter binding sites.
Little KY; Gorebig J; Carroll FI; Mapili J; Meador-Woodruff JH
Brain Res; 1996 Dec; 742(1-2):313-6. PubMed ID: 9117410
[TBL] [Abstract][Full Text] [Related]
11. Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum.
Dickinson SD; Sabeti J; Larson GA; Giardina K; Rubinstein M; Kelly MA; Grandy DK; Low MJ; Gerhardt GA; Zahniser NR
J Neurochem; 1999 Jan; 72(1):148-56. PubMed ID: 9886065
[TBL] [Abstract][Full Text] [Related]
12. Dopamine transporter development in postnatal rat striatum: an autoradiographic study with [3H]WIN 35,428.
Coulter CL; Happe HK; Murrin LC
Brain Res Dev Brain Res; 1997 Dec; 104(1-2):55-62. PubMed ID: 9466707
[TBL] [Abstract][Full Text] [Related]
13. Striatal dopamine, dopamine transporter, and vesicular monoamine transporter in chronic cocaine users.
Wilson JM; Levey AI; Bergeron C; Kalasinsky K; Ang L; Peretti F; Adams VI; Smialek J; Anderson WR; Shannak K; Deck J; Niznik HB; Kish SJ
Ann Neurol; 1996 Sep; 40(3):428-39. PubMed ID: 8797532
[TBL] [Abstract][Full Text] [Related]
14. [125I]RTI-55 binding to cocaine-sensitive dopaminergic and serotonergic uptake sites in the human brain.
Little KY; Kirkman JA; Carroll FI; Breese GR; Duncan GE
J Neurochem; 1993 Dec; 61(6):1996-2006. PubMed ID: 8245956
[TBL] [Abstract][Full Text] [Related]
15. Localization and quantification of the dopamine transporter: comparison of [3H]WIN 35,428 and [125I]RTI-55.
Coulter CL; Happe HK; Bergman DA; Murrin LC
Brain Res; 1995 Sep; 690(2):217-24. PubMed ID: 8535839
[TBL] [Abstract][Full Text] [Related]
16. Striatal [125I]RTI-55 binding sites in cocaine-abusing humans.
Little KY; Carroll FI; Butts JD
Prog Neuropsychopharmacol Biol Psychiatry; 1998 Apr; 22(3):455-66. PubMed ID: 9612843
[TBL] [Abstract][Full Text] [Related]
17. Characterization and localization of [125I]RTI-121 binding sites in human striatum and medial temporal lobe.
Little KY; Carroll FI; Cassin BJ
J Pharmacol Exp Ther; 1995 Sep; 274(3):1473-83. PubMed ID: 7562524
[TBL] [Abstract][Full Text] [Related]
18. Vesicular neurotransmitter transporters in Huntington's disease: initial observations and comparison with traditional synaptic markers.
Suzuki M; Desmond TJ; Albin RL; Frey KA
Synapse; 2001 Sep; 41(4):329-36. PubMed ID: 11494403
[TBL] [Abstract][Full Text] [Related]
19. Neurotensin receptors and dopamine transporters: effects of MPTP lesioning and chronic dopaminergic treatments in monkeys.
Goulet M; Morissette M; Grondin R; Falardeau P; Bédard PJ; Rostène W; Di Paolo T
Synapse; 1999 Jun; 32(3):153-64. PubMed ID: 10340626
[TBL] [Abstract][Full Text] [Related]
20. Dopamine transporter mRNA in autopsy studies of chronic cocaine users.
Chen L; Segal DM; Moraes CT; Mash DC
Brain Res Mol Brain Res; 1999 Nov; 73(1-2):181-5. PubMed ID: 10581411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
